Shenzhen-based MGI "sells technology" and will receive no less than $120 million in licensing fees
On October 28th, Shenzhen MGI Technology Co., Ltd. announced that it will reach a technology licensing cooperation with Swiss biotechnology company Swiss Rockets AG through its American subsidiary. According to the agreement, MGI Technology will grant an exclusive license/non-exclusive license for a patent, trademark, proprietary technology, and software related to a sequencing technology called "CoolMPS" to Swiss Rockets for development, production, and commercialization in global markets outside of the Asia-Pacific and Greater China regions. During the normal performance of this cooperation until the expiration of the exclusive licensing period, MGI Technology will receive a total licensing fee of no less than $120 million
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments